$MBRX KEEP ON WATCHLIST, VOLUME & PRICE SPIKE PREMARKET

Set your alerts for this stock has a history of 100% spikes, price up premarket on no news?

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development of oncology drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small molecule portfolios focus on the modulation of hard-to-target tumor cell signaling mechanisms and the metabolism of tumors.